Nyxoah (NYXH) Total Current Liabilities (2020 - 2026)
Nyxoah (NYXH) recorded quarterly Total Current Liabilities of $48.1 million in Q1 2026, down 15.66% quarter-over-quarter from $57.0 million in Q4 2025, and up 117.89% on a YoY basis from $22.1 million in Q1 2025.
Nyxoah (NYXH) Total Current Liabilities (2020 - 2026) Analysis & Trends
Nyxoah's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $48.1 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 117.89% year-over-year to $48.1 million; the TTM figure through Mar 2026 stood at $48.1 million (up 117.89% YoY), while the FY2025 annual figure was $57.0 million, up 147.72% from the prior year.
- Total Current Liabilities was $48.1 million for Q1 2026 at Nyxoah, down from $57.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $20.2 billion in Q3 2022 to a low of $14.2 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $1.4 billion across 5 years, with a median of $17.4 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities sank 99.92% in 2023, then jumped 147.72% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $15.2 million in 2022, then grew by 2.14% to $15.5 million in 2023, then jumped by 48.04% to $23.0 million in 2024, then surged by 147.72% to $57.0 million in 2025, then slipped by 15.66% to $48.1 million in 2026.
- The last three Total Current Liabilities figures came in at $48.1 million (Q1 2026), $57.0 million (Q4 2025), and $23.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | 48.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.07 Mn |
| Dec 31, 2025 | 56.99 Mn |
| Jun 30, 2025 | 23.71 Mn |
| Mar 31, 2025 | 22.06 Mn |
| Dec 31, 2024 | 23.01 Mn |
| Sep 30, 2024 | 17.37 Mn |
| Jun 30, 2024 | 17.64 Mn |
| Mar 31, 2024 | 15.18 Mn |
| Dec 31, 2023 | 15.54 Mn |
| Sep 30, 2023 | 15.74 Mn |
| Jun 30, 2023 | 16.59 Mn |
| Mar 31, 2023 | 15.39 Mn |
| Dec 31, 2022 | 15.21 Mn |
| Sep 30, 2022 | 20.17 Bn |
| Mar 31, 2022 | 14.19 Mn |
| Dec 31, 2021 | 13.24 Mn |
| Dec 31, 2020 | 7.63 Mn |